INmune Bio Inc expected to post a loss of 2 cents a share - Earnings Preview

Inmune Bio

02/05/2023 03:08

* INmune Bio Inc  INMB.OQ   INMB.O  is expected to report 
results on May 3. 
    * 
    * ​Refinitiv's mean analyst estimate for INmune Bio Inc is
for a
loss of 2 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for INmune Bio
Inc is
$18​, above​ its last closing price of $7.07. ​​​

This summary was machine generated May 2 at 02:08 GMT.  All
figures in US dollars  unless otherwise stated